Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Doximity Inc (NYSE: DOCS) closed at $43.85 in the last session, down -0.63% from day before closing price of $44.13. In other words, the price has decreased by -$0.63 from its previous closing price. On the day, 2.76 million shares were traded. DOCS stock price reached its highest trading level at $44.865 during the session, while it also had its lowest trading level at $43.6.
Ratios:
We take a closer look at DOCS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.45. For the most recent quarter (mrq), Quick Ratio is recorded 7.75 and its Current Ratio is at 7.75. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on December 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $63.
On November 21, 2025, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $65.
On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.BMO Capital Markets initiated its Market Perform rating on November 13, 2025, with a $55 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 01 ’25 when Wampler Kira Scherer sold 2,000 shares for $50.71 per share. The transaction valued at 101,420 led to the insider holds 19,839 shares of the business.
KIRA WAMPLER bought 2,000 shares of DOCS for $101,420 on Dec 01 ’25. On Nov 21 ’25, another insider, Cabral Timothy S, who serves as the Director of the company, sold 10,000 shares for $50.00 each. As a result, the insider received 500,000 and left with 3,221 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 8255694848 and an Enterprise Value of 7388597248. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.98, and their Forward P/E ratio for the next fiscal year is 25.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.29 while its Price-to-Book (P/B) ratio in mrq is 7.53. Its current Enterprise Value per Revenue stands at 11.892 whereas that against EBITDA is 29.068.
Stock Price History:
The Beta on a monthly basis for DOCS is 1.38, which has changed by -0.17173421 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $43.91. The 50-Day Moving Average of the stock is -24.96%, while the 200-Day Moving Average is calculated to be -27.50%.
Shares Statistics:
According to the various share statistics, DOCS traded on average about 1.93M shares per day over the past 3-months and 2919200 shares per day over the past 10 days. A total of 137.19M shares are outstanding, with a floating share count of 133.44M. Insiders hold about 29.14% of the company’s shares, while institutions hold 66.09% stake in the company. Shares short for DOCS as of 1764288000 were 5556952 with a Short Ratio of 2.87, compared to 1761868800 on 4199350. Therefore, it implies a Short% of Shares Outstanding of 5556952 and a Short% of Float of 4.14.
Earnings Estimates
Investors are keenly observing as 18.0 analysts analyze and rate. The current performance of Doximity Inc (DOCS) in the stock market.The consensus estimate for the next quarter is $0.32, with high estimates of $0.39 and low estimates of $0.26.
Analysts are recommending an EPS of between $1.67 and $1.35 for the fiscal current year, implying an average EPS of $1.57. EPS for the following year is $1.72, with 19.0 analysts recommending between $2.04 and $1.47.
Revenue Estimates
According to 18 analysts,. The current quarter’s revenue is expected to be $181.63M. It ranges from a high estimate of $192.21M to a low estimate of $180.3M. As of. The current estimate, Doximity Inc’s year-ago sales were $168.6MFor the next quarter, 18 analysts are estimating revenue of $150.34M. There is a high estimate of $158.71M for the next quarter, whereas the lowest estimate is $147.8M.
A total of 20 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $664.29M, while the lowest revenue estimate was $625M, resulting in an average revenue estimate of $644.96M. In the same quarter a year ago, actual revenue was $570.4MBased on 20 analysts’ estimates, the company’s revenue will be $716.33M in the next fiscal year. The high estimate is $773.46M and the low estimate is $688.7M.
